Explore the details of the Abbvie Inc. V. Prinston Pharmaceutical Inc. case under case number 1:24-cv-00152 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00152
Filing Date
Feb 5, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Prinston Pharmaceutical Inc. -
Solco Healthcare US, LLC -
Zhejiang Huahai Pharmaceutical Co., Ltd. -
AbbVie Inc. -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11690845B2
-US11690854B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 5, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,690,845 B2; 11,690,854 B2. (mpb) (Entered: 02/06/2024)PACER Document
Feb 5, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/23/2026. (mpb) (Entered: 02/06/2024)PACER Document
Feb 5, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 02/06/2024)PACER Document
Feb 5, 2024COMPLAINT filed with Jury Demand against Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, Zhejiang Huahai Pharmaceutical Co., Ltd. ( Filing fee $ 405, receipt number ADEDC-4330996.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(mpb) (Entered: 02/06/2024)PACER Document
Feb 5, 2024Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (mpb) (Entered: 02/06/2024)PACER Document
Feb 23, 2024Summonses Issued as to Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, and Zhejiang Huahai Pharmaceutical Co., Ltd. on 2/23/2024. (Attachments: # 1 Summons Issued Solco Healthcare US, LLC, # 2 Summons Issued Zhejiang Huahai Pharmaceutical Co., Ltd.)(jfm) (Entered: 02/23/2024)PACER Document
Feb 23, 2024SUMMONS Returned Executed by AbbVie Inc..Solco Healthcare US, LLC served on 2/23/2024, answer due 3/15/2024. (Tigan, Jeremy) (Entered: 02/23/2024)PACER Document
Feb 23, 2024SUMMONS Returned Executed by AbbVie Inc..Prinston Pharmaceutical Inc. served on 2/23/2024, answer due 3/15/2024. (Tigan, Jeremy) (Entered: 02/23/2024)PACER Document
Feb 28, 2024AFFIDAVIT of Service for Summons, Complaint and related papers served on Zhejiang Huahai Pharmaceutical Co., Ltd. on February 23, 2024, filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 02/28/2024)PACER Document
Mar 1, 2024STIPULATION and [Proposed] Order Regarding Consolidation by AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc.. (Dellinger, Megan) (Entered: 03/01/2024)PACER Document
Mar 5, 2024SO ORDERED, re (7 in 1:24-cv-00153-JLH, 194 in 1:22-cv-01423-JLH, 7 in 1:24-cv-00154-JLH, 10 in 1:24-cv-00151-JLH, 10 in 1:24-cv-00152-JLH) Stipulation and Order regarding Consolidation for all purposes. Signed by Judge Jennifer L. Hall on 3/5/2024. Associated Cases: 1:22-cv-01423-JLH, 1:24-cv-00151-JLH, 1:24-cv-00152-JLH, 1:24-cv-00153-JLH, 1:24-cv-00154-JLH(ceg) (Entered: 03/05/2024)PACER Document
Feb 5, 2024No Summons Issued. (mpb)PACER Document
Feb 7, 2024Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:24-cv-00151-JLH, 1:24-cv-00152-JLH, 1:24-cv-00153-JLH, 1:24-cv-00154-JLH (rjb)PACER Document
Mar 5, 2024Case associated with lead case: Create association to 1:22-cv-01423-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:22-cv-01423-JLH ONLY. (ceg)PACER Document